COMMUNIQUÉS West-GlobeNewswire

Telix Pharmaceuticals and Memorial Sloan Kettering Cancer Center Announce Renal Cancer Collaboration

13/12/2017 - 23:30

MELBOURNE, Australia and NEW YORK, Dec. 14, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“ Telix ”, the “ Company ”), an Australian biopharmaceutical company focused on the development of diagnostic [...]

DiaMedica Therapeutics Announces Non-Brokered Private Placement

13/12/2017 - 22:48

MINNEAPOLIS, Dec. 13, 2017 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ”) (TSX-V: DMA ) (OTCQB:DMCAF), announces that, subject to TSX Venture Exchange approval, it is undertaking a non-brokered [...]

Nabriva Therapeutics Added to NASDAQ Biotechnology Index

13/12/2017 - 22:05

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical stage biopharmaceutical company engaged in the research and development of novel anti- [...]

Flexion Therapeutics Announces Acquisition of Novel, Non-Opioid Asset for Osteoarthritis of the Knee

13/12/2017 - 22:05

Acquisition complements existing portfolio with an innovative, locally administered therapeutic intended to provide persistent effective concentrations of IL-1Ra in the knee for at least a year New preclinical program [...]

ExactCare Pharmacy Welcomes Terry Rogers as Chief Growth Officer

13/12/2017 - 22:00

CLEVELAND, Dec. 13, 2017 (GLOBE NEWSWIRE) -- ExactCare® Pharmacy has expanded its Executive Leadership Team, welcoming seasoned health care executive Terry Rogers to the newly created role of Chief Growth Officer (CGO [...]

ContraVir Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until December 21, 2017

13/12/2017 - 22:00

EDISON, N.J., Dec. 13, 2017 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, today [...]

AveXis Announces Plan to Initiate Phase 1 Trial in SMA Type 2 Utilizing Intrathecal Delivery of AVXS-101

13/12/2017 - 22:00

– The FDA notified AveXis it may initiate the Phase 1 trial in SMA Type 2 based on a review of data provided by the company; trial to commence immediately – – The trial will evaluate safety, dosing and proof of concept [...]

Emerald Health Announces No Material Change

13/12/2017 - 21:00

VICTORIA, British Columbia, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (the “Company”) is issuing this press release in response to a request by the Investment Industry [...]

RedHawk Initiates Plan to Eliminate Debt

13/12/2017 - 21:00

LAFAYETTE, La., Dec. 13, 2017 (GLOBE NEWSWIRE) -- RedHawk Holdings Corp. (OTCQB:IDNG) (“RedHawk” or the “Company”) announced today that it has received a favorable order from the Circuit Court of the Twelfth Judicial [...]

Tivity Health and Linkwell Health Recognized for Efforts to Engage Seniors through Digital Platform

13/12/2017 - 20:30

NEW YORK and FRANKLIN, Tenn., Dec. 13, 2017 (GLOBE NEWSWIRE) -- Tivity Health, Inc. (NASDAQ: TVTY ), the leading provider of fitness and health improvement programs for older adults, and Linkwell Health, the leading [...]

CohBar Announces Approval for Listing on the NASDAQ Capital Market

13/12/2017 - 18:53

NASDAQ Trading to Begin on December 15, 2017 Under Existing Ticker Symbol CWBR MENLO PARK, Calif., Dec. 13, 2017 (GLOBE NEWSWIRE) -- CohBar, Inc. (OTCQX:CWBR) (TSXV:COB.U), an innovative biotechnology company focused on [...]

Tauriga Sciences, Inc. Fully Repays $80,000 USD 5% Face Value Convertible Debenture Issued to GS Capital Partners, LLC on June 27, 2017 for One Time Cash Payment of $108,164.38 USD

13/12/2017 - 18:51

NEW YORK, NY, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG ) ("Tauriga" or the "Company"), engaged in building business through the development, distribution, and licensing of proprietary [...]

Tyme to Present at Biotech Showcase™ 2018

13/12/2017 - 18:00

NEW YORK, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Tyme Inc. (Nasdaq: TYME ), a clinical-stage biotechnology company developing cancer therapeutics, today announced that management will present a company overview at the [...]

CyberFuels Inc. announces distribution expansion throughout Canada and the USA

13/12/2017 - 17:15

PALM BEACH, Fla., Dec. 13, 2017 (GLOBE NEWSWIRE) -- EncounterCare Solutions (OTC:ECSL) announces that its subsidiary, CyberFuels Inc., is pleased to announce that it has signed a distribution contract with RLT Fuel [...]

Solera Health Expands Its Board of Directors with the Addition of Healthcare Industry Leader Mary Langowski

13/12/2017 - 16:00

PHOENIX, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Solera Health today announced the appointment of healthcare industry veteran Mary Langowski as an independent director to the company’s board, effective immediately. Mary joins [...]

Ossur Hf : Financial calendar 2018

13/12/2017 - 15:41

Announcement no. 87/2017 Financial calendar 13 December 2017 Financial calendar 2018 Össur's financial calendar for 2018 Interim Report Q1 2018 25 April 2018 Interim Report Q2 2018 25 July 2018 Interim Report Q3 2018 24 [...]

Allakos Secures $100 Million In Series B Financing

13/12/2017 - 15:00

Proceeds will support advancement of AK002 in five disease areas Lead clinical program evaluating AK002 in eosinophilic gastroenteritis, an inflammatory gastrointestinal disease SAN CARLOS, Calif., Dec. 13, 2017 (GLOBE [...]

NSS Labs Announces Industry’s First Breach Prevention System Group Test Results

13/12/2017 - 15:00

AUSTIN, Texas, Dec. 13, 2017 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent fact-based cybersecurity guidance, today announced the results of its Breach Prevention Systems (BPS) [...]

Stemline Therapeutics Presents Detailed SL-401 Pivotal Data in BPDCN at ASH and Kicks Off its BPDCN Awareness Campaign; Updated Results From Ongoing Trials in Additional Malignancies Also Presented

13/12/2017 - 14:36

NEW YORK, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, presented detailed data [...]